I've noticed recently that potential approval is being mentioned more in interviews and announcements etc. I think everyone should be confident that management are on the right path and not be critical as some here have been. Its the low share price that is the trigger and reason for peoples frustration which is understandable. The people who will influence Immutep's success don't look at Hotcopper.
I have always been curious as to why in Immutep's branding. lag3 immunotherapy is mentioned. Is lag 3 going to dominate treatment and be a household name that people recognise instantly.
I've noticed recently that potential approval is being mentioned...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $343.1M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.8¢ | 23.0¢ | $365.4K | 1.559M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 33 | 1353468 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 856736 | 8 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| IMM (ASX) Chart |